No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6680773 |
chr1:47449486-47449487 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs556143659 |
chr1:47449497-47449498 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs79171009 |
chr1:47449566-47449567 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs528780076 |
chr1:47449658-47449659 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs535334344 |
chr1:47449719-47449720 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs146975839 |
chr1:47449730-47449731 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs572239519 |
chr1:47449743-47449744 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs545867018 |
chr1:47449746-47449747 |
Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs564145314 |
chr1:47449801-47449802 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs138138084 |
chr1:47449804-47449805 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs543792468 |
chr1:47449841-47449842 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs9429123 |
chr1:47449844-47449845 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs143713596 |
chr1:47449850-47449851 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs61284575 |
chr1:47449887-47449888 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs377420255 |
chr1:47449895-47449896 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs544085602 |
chr1:47449896-47449897 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs116315815 |
chr1:47449901-47449902 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs61411220 |
chr1:47449905-47449906 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs562700469 |
chr1:47449908-47449909 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs114990562 |
chr1:47449930-47449931 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs531093295 |
chr1:47449979-47449980 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs552254445 |
chr1:47449987-47449988 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs537411360 |
chr1:47450049-47450050 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs113494180 |
chr1:47450064-47450065 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs563701882 |
chr1:47450067-47450068 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs58436476 |
chr1:47450071-47450072 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs397864261 |
chr1:47450072-47450073 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs397863808 |
chr1:47450073-47450074 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs570471292 |
chr1:47450138-47450139 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs181816470 |
chr1:47450169-47450170 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs549744581 |
chr1:47450269-47450270 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs187208415 |
chr1:47450276-47450277 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs7527237 |
chr1:47450280-47450281 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs35899660 |
chr1:47450298-47450299 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs553564657 |
chr1:47450313-47450314 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs372976551 |
chr1:47450342-47450343 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs115670864 |
chr1:47450353-47450354 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs567613505 |
chr1:47450358-47450359 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs557873962 |
chr1:47450359-47450360 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs34059350 |
chr1:47450364-47450365 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs191999403 |
chr1:47450377-47450378 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs180849019 |
chr1:47450416-47450417 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs536689642 |
chr1:47450420-47450421 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs562098788 |
chr1:47450464-47450465 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs185498337 |
chr1:47450468-47450469 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs375744144 |
chr1:47450522-47450523 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs190160024 |
chr1:47450602-47450603 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs182798962 |
chr1:47450603-47450604 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs111578234 |
chr1:47450620-47450621 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs367977001 |
chr1:47450622-47450623 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|